Although the scientific relevance on the aforementioned cardiovascular risk factor alterations by tirzepatide are going to be assessed within the prepared cardiovascular result examine SURPASS-CVOT ( "type":"clinical-trial","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Investigati